MANCHESTER KEITH S Insider Trading -- Recent SEC Form 4 Transactions
MANCHESTER KEITH S (CIK 1244828) reported 36 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-11-18). Recent activity: Sell ROIV (79,461 shares), Sell ROIV (550,280 shares), Sell ROIV (18,927 shares), Sell ROIV (131,073 shares), Sell ROIV (2.6M shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-11-18 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 79,461 | $3.1M |
| 2026-11-18 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 550,280 | $21.6M |
| 2026-11-18 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 18,927 | $737,964 |
| 2026-11-18 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 131,073 | $5.1M |
| 2026-11-18 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 2.6M | $0 |
| 2026-11-18 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 15,969 | $0 |
| 2026-11-18 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 385,620 | $0 |
| 2026-11-18 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 75,716 | $2.9M |
| 2026-11-18 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 525,507 | $20.1M |
| 2026-11-18 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 798 | $30,516 |
| 2026-09-18 | Roivant Sciences Ltd. (ROIV) | Director | Buy | 5,054 | $0 |
| 2026-06-30 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 325,000 | $11.1M |
| 2026-06-30 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 300,783 | $10.2M |
| 2026-06-30 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 200,000 | $6.9M |
| 2026-06-30 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 600,000 | $20.8M |
| 2026-06-30 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 12,380 | $436,766 |
| 2026-06-30 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 200,000 | $7.1M |
| 2026-02-13 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 425,000 | $11.3M |
| 2026-02-13 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 150,000 | $4.0M |
| 2026-02-13 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 275,000 | $7.4M |
| 2026-02-13 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 150,784 | $4.0M |
| 2026-02-13 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 225,000 | $6.0M |
| 2025-12-18 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 275,000 | $6.3M |
| 2025-12-18 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 642,282 | $14.8M |
| 2025-12-18 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 432,718 | $10.0M |
Source: SEC Form 4 filings · as of 2026-11-18